Is Mounjaro available in South Africa?
Published 7 April 2026 · Updated 17 July 2026
Yes, Mounjaro is available in South Africa. SAHPRA, the South African Health Products Regulatory Authority, registered Mounjaro (tirzepatide) and it reached the local market in December 2024, initially for type 2 diabetes. In October 2025, SAHPRA approved a second indication: chronic weight management in adults.
That second approval changed the picture for Mounjaro in South Africa. Doctors can now include it in a weight management treatment plan where it is clinically appropriate, alongside a reduced-calorie diet and increased physical activity. The medicine is supplied as the Mounjaro KwikPen, a multi-dose pen that holds four weekly doses.
This guide covers what SAHPRA has registered, which doses are in the country, what the clinical trials showed, how to store and travel with the pens, what the public sector offers, and what to check before you consider treatment.
What is Mounjaro?
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medicine developed by Eli Lilly. It acts on two gut-hormone receptors at the same time, GIP and GLP-1. That dual action reduces appetite, slows stomach emptying and improves how the body handles blood sugar.
In South Africa, Mounjaro is distributed by Aspen Pharmacare in partnership with Lilly. It is a Schedule 4 medicine, so it always requires a doctor's assessment and authorisation, and it is dispensed by licensed pharmacies only.
If this class of medicine is new to you, this overview of GLP-1 medicines explains how they work and who they suit.
Is Mounjaro approved by SAHPRA?
Yes. Mounjaro is fully registered with SAHPRA. The timeline matters because the two indications arrived separately.
Aspen launched Mounjaro in South Africa in December 2024 for adults with type 2 diabetes. In October 2025, SAHPRA approved tirzepatide for chronic weight management: as an addition to a reduced-calorie diet and increased physical activity in adults with obesity, or who are overweight with at least one weight-related condition.
The registered use is alongside diet and activity changes, not instead of them. That is also how the clinical trials that support the registration were run.
Registration also settled the presentation. The multi-dose KwikPen has replaced the single-dose vials Aspen launched with, so the pen is what South African pharmacies now stock.
Who is Mounjaro registered for in South Africa?
For weight management, the SAHPRA-registered use covers adults with a BMI of 30 or more, or a BMI of 27 or more with at least one weight-related condition. Common qualifying conditions include high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnoea and cardiovascular disease.
BMI is a screening number, not a full picture. A doctor also weighs up your medical history, current medicines, previous weight loss attempts and any contraindications before deciding whether treatment is clinically appropriate.
Mounjaro is not registered for cosmetic weight loss, for people in a healthy weight range, or for anyone under 18. It is also not a first step: South African treatment guidelines still put diet, activity and behaviour change at the base of any plan, with medicine added where that foundation is not enough on its own.
Which Mounjaro doses are available in South Africa?
South Africa receives the Mounjaro KwikPen, a pre-filled multi-dose pen. Each pen contains four weekly doses. Treatment starts low and steps up over several months so the body can adjust.
| KwikPen strength | Typical place in the schedule |
|---|---|
| 2.5 mg weekly | Starting dose, usually weeks 1 to 4 |
| 5 mg weekly | First step up, from week 5 |
| 7.5 mg weekly | Increase if needed and tolerated |
| 10 mg weekly | Increase if needed and tolerated |
| 12.5 mg weekly | Increase if needed and tolerated |
| 15 mg weekly | Maximum registered dose |
Your doctor decides the pace of increases based on how you respond. Not everyone needs the maximum dose; many people settle at a middle dose that balances results and side effects.
A practical note: the KwikPen must be stored in a fridge at 2 to 8 degrees Celsius. The storage and travel rules, including what load shedding does and does not threaten, are covered in the next two sections.
Distribution has widened since launch to the major pharmacy groups, including Dischem and Clicks, and to independent community pharmacies. Demand is high, though, and individual strengths do go out of stock at branch level. If a pharmacy cannot fill the exact strength on your plan, do not split or double up doses from a different pen strength on your own; speak to your doctor first, because the schedule can usually be adjusted safely.
How do you store Mounjaro in South Africa?
Unopened Mounjaro pens live in the fridge at 2 to 8 degrees Celsius. The medicine must never freeze: a pen that has frozen, even once, must not be used, because freezing damages the active ingredient in ways you cannot see or taste.
Once you take the first dose, the rules loosen. Lilly states the in-use KwikPen may be kept below 30 degrees Celsius for up to 30 days, and that moving it between fridge and room temperature within that window does not harm the medicine. After 30 days, or after the fourth weekly dose, the pen is discarded. Never store the pen with a needle attached, because that can draw in air bubbles that affect dose accuracy.
Load shedding threatens the fridge less than most people assume. A closed fridge holds a safe temperature for a few hours, so a two-hour outage needs nothing more than a shut door. For longer outages, move pens to a cooler box with ice packs, wrapped in a cloth so the pen never rests directly against the packs and cannot freeze. If the power was off overnight and you are unsure, ask your pharmacist before injecting; for an in-use pen, the 30-day room-temperature allowance usually means nothing was lost.
Can you travel with Mounjaro pens?
Yes, and the 30-day in-use allowance below 30 degrees Celsius makes most trips straightforward. Only two things ruin a pen in transit: freezing, and heat above 30 degrees. Plan around those and the rest is admin.
On flights, pens go in hand luggage, never in checked baggage. The cargo hold can drop below freezing, and a frozen pen must be discarded. Airport scanners do not harm the medicine. Keep the pen in its original box with the pharmacy label, and for international trips carry a short letter from your doctor confirming the treatment plan, because customs officials may ask about injectable medicine and needles.
South African summer heat is the bigger everyday risk. A parked car passes 30 degrees within minutes, so never leave a pen in the cubbyhole or boot. For road trips, a small medical cooler pouch with a gel pack holds the pen in range for hours; again, keep the pen from touching the pack directly.
If a trip runs longer than 30 days, talk to your doctor about timing your collection so a fresh pen is waiting when you return. Injection technique away from home stays exactly the same, covered in how to inject Mounjaro.
How well does Mounjaro work for weight loss?
The key evidence is SURMOUNT-1, a 72-week trial of 2,539 adults with obesity or overweight, published in the New England Journal of Medicine. Average weight loss was 15% of body weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, compared with about 3% on placebo. Individual results vary.
The responder rates tell the same story. Roughly nine in ten participants on the two higher doses lost at least 5% of their body weight, compared with about a third of the placebo group. Individual results vary.
In a later head-to-head trial, SURMOUNT-5, tirzepatide produced greater average weight loss than semaglutide 2.4 mg over 72 weeks: 20.2% against 13.7%. Individual results vary. For a fuller comparison of the two medicines, see Mounjaro vs Ozempic.
Trial participants also followed a reduced-calorie diet and an activity plan. The medicine supports those changes; it does not replace them.
What are the side effects of Mounjaro?
The most common side effects are digestive: nausea, diarrhoea, constipation, vomiting and indigestion. They are usually mild to moderate, appear most often when the dose increases, and tend to settle as the body adjusts. Slower dose increases, smaller meals and good hydration all reduce the impact.
Mounjaro is not suitable for everyone. It should not be used in pregnancy or while breastfeeding, or by people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. A history of pancreatitis needs careful discussion with a doctor. Severe, persistent stomach pain can signal pancreatitis: seek medical care immediately.
Less common effects are worth knowing too. Injection-site redness or itching usually passes and rotating sites helps. Gallbladder problems occur in a small number of people, typically signalled by pain under the right ribs after meals. And anyone who also takes insulin or a sulfonylurea for diabetes needs closer monitoring, because the combination can drop blood sugar too low; that adjustment is a doctor's call, not a self-made one.
Our separate guide on side effects covers frequency, duration and management in detail, including the small number of serious risks worth knowing by name.
What does Mounjaro cost in South Africa?
Published South African pharmacy prices in 2026 range from roughly R3,600 to R8,200 per KwikPen depending on the strength. One pen holds four weekly doses, so a pen covers about a month. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy. We report these figures as market information only.
The pen price is not the whole budget. A realistic monthly figure also includes doctor consultations, any baseline blood tests your doctor requests, and follow-up reviews as the dose changes.
Medical aid schemes generally do not fund weight management medicine, because obesity is not a Prescribed Minimum Benefit condition. Some schemes fund tirzepatide for type 2 diabetes under chronic benefits, and scheme positions are shifting year by year, so check your own plan's rules.
For the full cost picture, including consultation and monitoring costs, read how much Mounjaro costs in South Africa.
Can you get Mounjaro at a government hospital or clinic?
No. Mounjaro is not stocked in South Africa's public sector, and neither is any other medicine in this class. Access in 2026 runs through private doctors and private pharmacies only, which is why cost dominates so much of the conversation.
That may not be permanent. Spotlight reported in February 2026 that the National Essential Medicines List Committee is prioritising a review of GLP-1 medicines for the public sector list, though no timeline has been committed. The World Health Organization added tirzepatide and three GLP-1 medicines to its Model List of Essential Medicines in September 2025, and a WHO listing typically strengthens the case for national adoption.
The scale of the question is large: around 28% of South African adults live with obesity, and researchers estimate millions would meet treatment criteria. For now, public sector patients are limited to diet, activity support and older medicines, and anyone considering tirzepatide needs a private route. The wider policy picture sits in GLP-1 in South Africa.
How do you avoid counterfeit Mounjaro?
Genuine Mounjaro reaches you one way: a licensed pharmacy dispenses it against a doctor-confirmed treatment plan. Any seller that skips the doctor step, whether a website, a social media account or a WhatsApp contact, is not selling the registered product, whatever the packaging claims.
SAHPRA has warned the public about falsified, compounded and substandard products in this class being sold through websites and social media channels. These copies are not evaluated for safety, quality or efficacy, and their contents are unverified. Compounded tirzepatide has no SAHPRA registration in any form.
The practical checks are simple. The pen should arrive cold from a pharmacy fridge, sealed in Eli Lilly packaging with a batch number and expiry date, dispensed by a pharmacy you can walk into or verify with the South African Pharmacy Council. A price far below the published range is a warning sign, not a bargain.
Suspicious products can be reported to SAHPRA's 24-hour hotline on 0800 204 307. The safe and unsafe online routes are compared in can you buy Ozempic online legally and safely.
Can you switch to Mounjaro from another injection?
Yes. Switching to Mounjaro from another injectable treatment is common, and safe when a doctor manages it. The usual reasons are a results plateau, side effects that will not settle on the current medicine, or persistent stock problems with a specific product.
Two rules shape every switch. First, doses do not transfer: tirzepatide and semaglutide are different molecules with different dosing ladders, so everyone starts Mounjaro at 2.5 mg weekly regardless of the dose they were on before. Second, timing follows the old medicine's schedule: after a weekly injection, the first Mounjaro dose typically lands about a week after the last old dose, while after a daily injection such as liraglutide the changeover is quicker. No washout period is required.
Expect the adjustment period to repeat. Appetite effects and mild digestive side effects often return at the new starting dose and at each step up, then settle. The molecule comparison is unpacked in semaglutide vs tirzepatide. The right option, and the timing of any change, is decided by a doctor on assessment.
How does prescribing work in South Africa?
Because Mounjaro is a Schedule 4 medicine, the process is the same everywhere in South Africa: a doctor assesses your health, weight history and goals. Where treatment is clinically appropriate, the doctor confirms a treatment plan, and a licensed pharmacy dispenses the medicine.
The assessment can happen at any GP practice or through a doctor-led telehealth service. Blood pressure, medical history, current medicines and contraindications are all checked first. Expect follow-up reviews as well: dose changes, side effects and progress should be monitored by the same doctor over time, not handled as a once-off.
The clinical process, including what information a doctor typically asks for, is explained in how Mounjaro prescribing works in South Africa.
Frequently asked questions
Can you get Mounjaro in South Africa?
Yes. Mounjaro is registered with SAHPRA and stocked by licensed South African pharmacies, subject to stock levels. As a Schedule 4 medicine it requires a doctor's assessment and authorisation.
When did Mounjaro become available in South Africa?
December 2024, initially for type 2 diabetes. SAHPRA approved the chronic weight management indication in October 2025.
Is Mounjaro the same as Ozempic?
No. Mounjaro contains tirzepatide, which acts on two hormone receptors, while Ozempic contains semaglutide, which acts on one. They are made by different companies and dosed differently.
Is Mounjaro available at Dischem or Clicks?
Yes, major pharmacy groups stock the Mounjaro KwikPen, although availability fluctuates with demand and supply. It is worth phoning your branch ahead of time.
Do you need to see a doctor for Mounjaro in South Africa?
Yes. It is a Schedule 4 medicine, so a doctor must assess you and authorise treatment before a pharmacy can dispense it. The assessment can happen in person or through a registered telehealth practice.
How long can Mounjaro stay out of the fridge?
Up to 30 days below 30 degrees Celsius once a KwikPen is in use, according to Lilly, after which the pen is discarded. Unopened pens stay in the fridge at 2 to 8 degrees Celsius and must never freeze.
Can you fly with Mounjaro?
Yes. Pack pens in hand luggage in a small cooler pouch, never in checked baggage, because the cargo hold can drop below freezing and a frozen pen must not be used. Carry the original packaging and a letter from your doctor for international trips.
Is Mounjaro available at government hospitals in South Africa?
No. The public sector does not stock it in 2026, although the national Essential Medicines List committee is reviewing the class. Access currently runs through private doctors and pharmacies.
Sources
- SAHPRA: Mounjaro professional information (tirzepatide)
- Aspen Pharmacare: local availability of Lilly's Mounjaro
- NEJM: Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)
- Medical Brief: SAHPRA grants Mounjaro approval for weight loss
- Lilly: How should the Mounjaro KwikPen be stored?
- SAHPRA: Public urged to use registered products
- Spotlight: Obesity medicines are needed in SA's public sector
This article is general information, not personal medical advice. Treatment decisions are made by a registered doctor on assessment. Individual results vary.
